Companies: 10,795·Total market cap: $144.5T
PAVmed Inc.

PAVmed Inc.

PAVMNASDAQHealthcare● Active
$5.32
$-0.13(-2.39%)
Market Cap$2857037
P/E Ratio
52W High$28.44
52W Low$5.1
SEC Filings

PAVmed Inc. (PAVM) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001624326 · PAVM · NASDAQ · as of Jun 8, 2026

Filing snapshot

681
Total Filings
SCHEDULE 13G
Latest Form
2026-05-15
Most Recent
2016
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001624326 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-27
Fiscal Year End
Mar 27, 2026
Accession No.
0001437749-26-010115
Primary Document
pavm20251231_10k.htm
Source: data.sec.gov · CIK 0001624326 · Accession 0001437749-26-010115

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-14
8-KCurrent Report
8-K
2026-05-15Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
8-KCurrent Report
8-K
2026-05-15
View
10-QQuarterly Report
FORM 10-Q
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-11
View
DEF 14AProxy Statement
DEF 14A
2026-04-30
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-30
View
ARSARS
ARS
2026-04-30
View
EFFECTEFFECT
EFFECT
2026-04-29
View
424B3424B3
424B3
2026-04-29
View
CORRESPCORRESP
CORRESP
2026-04-27
View
UPLOADUPLOAD
UPLOAD
2026-04-24
View
S-3Shelf Registration
S-3
2026-04-21
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-14
View
3Initial Statement of Beneficial Ownership
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-13
View
Showing 1–15 of 527 filingsForm 4 / 144 hidden· 681 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001624326  |  Exchange: NASDAQ · Healthcare

PAVmed Inc. (NASDAQ: PAVM) has submitted 681 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001624326, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is PAVmed Inc.'s most comprehensive regulatory disclosure. The most recent PAVmed Inc. 10-K was filed on 2026-03-27 for fiscal year ending 2026. Historical PAVM 10-K annual reports are available from 2014 through 2026.

Investors researching PAVmed Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

PAVM SEC Filings · 8 questions

PAVmed Inc. (PAVM) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 681 filings and access original documents at no cost. PAVmed Inc.'s CIK is 0001624326.

PAVM SEC filingsPAVmed Inc. SEC documentsfind PAVM 10-K